🇺🇸 FDA
Patent

US 10888554

Salts of heterocyclic modulators of HIF activity for treatment of disease

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 10888554 (Salts of heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545